Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
abbreviation
|
| gptkbp:calculationMethod |
(Cost of intervention A - Cost of intervention B) / (Effect of A - Effect of B)
|
| gptkbp:contrastsWith |
costs and health outcomes
|
| gptkbp:expressedIn |
cost per life-year gained
cost per quality-adjusted life year (QALY) gained |
| https://www.w3.org/2000/01/rdf-schema#label |
ICERs
|
| gptkbp:importantFor |
resource allocation
drug reimbursement health policy decisions |
| gptkbp:interpretedBy |
lower ICERs indicate more cost-effective interventions
|
| gptkbp:measures |
cost-effectiveness
|
| gptkbp:reportsTo |
cost-effectiveness analyses
|
| gptkbp:standsFor |
Incremental Cost-Effectiveness Ratios
|
| gptkbp:threshold |
gptkb:Country
|
| gptkbp:usedBy |
gptkb:government_agency
health insurers National Institute for Health and Care Excellence (NICE) |
| gptkbp:usedFor |
health technology assessment
|
| gptkbp:usedIn |
health economics
pharmacoeconomics |
| gptkbp:bfsParent |
gptkb:S.H.I.E.L.D._(MCU)
|
| gptkbp:bfsLayer |
8
|